Compass Financial Advisors LLC Eli Lilly & CO Transaction History

Compass Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $73,929 - $86,827	-238 Reduced 11.14%	1,898 $651,000
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $14,148 - $16,485	-44 Reduced 2.02%	2,136 $781,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $3,261 - $3,716	-11 Reduced 0.5%	2,180 $705,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $52,958 - $62,181	-190 Reduced 7.98%	2,191 $710,000
Q4 2021 Feb 24, 2022	BUY	$224.85 - $279.04 $535,367 - $664,394	2,381 New	2,381 $658,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Compass Financial Advisors LLC with notifications on news.